Skip to main content
Clinical Trials/NCT01882075
NCT01882075
Terminated
Phase 4

Automated Administration of Fluid Administration Thanks to Hemodynamic Parameters and Cardiac Output During General Anesthesia

Hopital Foch1 site in 1 country2 target enrollmentJune 2013
ConditionsAnesthesia

Overview

Phase
Phase 4
Intervention
Open loop
Conditions
Anesthesia
Sponsor
Hopital Foch
Enrollment
2
Locations
1
Primary Endpoint
Mean cardiac output index during the surgery
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

The investigators want to test during anesthesia the feasibility of a closed-loop automated fluid replacement system using cardiac output monitoring as the input value.

Detailed Description

The optimization of the cardiac output is an important goal during anesthesia to decrease the postoperative morbidity, mortality and the care costs. We want to test if the closed-loop fluid administration is feasible. Two groups will be compared. In all cases: * anesthesia will be provided by a closed-loop which aim is to maintain bispectral index between 40 and 60 using propofol and remifentanil. This method permits to have similar depths of anesthesia in all cases. * cardiac output will be continuously monitored by LidCO. In one group, fluid replacement is decided by the physician; in the other, fluid replacement is automated using a closed-loop system.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
December 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients aged 18-75 years
  • Scheduled for abdominal surgery under general anesthesia and requiring an invasive arterial blood pressure monitoring
  • Consenting to participate in the study

Exclusion Criteria

  • Pregnant, breast feeding women
  • Pacemaker
  • Psychiatric disease, dementia, brain disease
  • Contraindication to hydroxyethyl starch
  • Inability to measure pulse pressure variability : arrhythmia, spontaneous breathing, or tidal volume \< 7 ml/Kg

Arms & Interventions

Open loop

fluid replacement (hydroxyethyl starch 130/0.4) is decided by the physicians according to continuous cardiac output measured by LidCO rapid device

Intervention: Open loop

Closed-loop

Fluid replacement is automated. An algorithm has been developed ; the input value is continuous cardiac output measured by LidCO rapid device; the computer steers iv infusion of hydroxyethyl starch 130/0.4.

Intervention: Closed-loop

Outcomes

Primary Outcomes

Mean cardiac output index during the surgery

Time Frame: One day after anesthesia

Secondary Outcomes

  • cardiac index during the surgery(One day after anesthesia)
  • arterial hypertension(One day after anesthesia)
  • Dysfunction of the closed-loop fluid device(One day after anesthesia)
  • Time before reaching maximizing cardiac output(One day after anesthesia)
  • Volume of fluid replacement during surgery(One day after anesthesia)

Study Sites (1)

Loading locations...

Similar Trials